| Browse All

Cardiol Therapeutics Inc. (CRDL)

Healthcare | Drug Manufacturers - Specialty & Generic | Oakville, Canada | NasdaqCM
1.51 USD +0.10 (7.092%) ⇧ (April 17, 2026, 4 p.m. EDT)
After hours: 1.49 -0.02 (-0.019%) ⇩ (April 17, 2026, 7:43 p.m. EDT)

Short-term: ★★★☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ★☆☆☆☆
Hot Take | April 18, 2026, 11:34 p.m. EDT

This is a binary event-driven stock with no dividend safety, negative earnings, and poor forecasting model confidence (high H-stat), making it a bad buy-and-hold; however, the options market is aggressively one-sidedly bullish on a specific upside target, suggesting retail/speculative capital is positioning for a price spike before the June 2026 milestones, yet the lack of short coverable put buying makes this a high-risk momentum play rather than a solid fundamental entry.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.079456
AutoETS0.079545
MSTL0.080269
AutoARIMA0.081872

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 20%
H-stat 39.91
Ljung-Box p 0.000
Jarque-Bera p 0.000
Excess Kurtosis 0.78
Attribute Value
Sector Healthcare
Debt to Equity Ratio 0.702
Market Cap 168,636,928
Forward P/E -8.79
Beta 0.43
Website https://www.cardiolrx.com

As of April 18, 2026, 11:34 p.m. EDT: Call volume is heavily skewed towards 2.5 strikes (near ATM) across expirations through Q3, with OTM OI at 100% of total volume in most legs. This indicates pure directional bullish speculation anchored to a ~65.6% perceived upside target. Notably, there is virtually zero call volume in the calls data provided, but high Open Interest (OI) suggests existing long exposure. Put volume is negligible (0-1 contracts) with zero OTM positioning and 0% OTM OI in the provided summary, indicating almost no hedging or bearish positioning relative to the calls. The stark lack of put activity compared to call positioning creates a highly one-sided gamma exposure where market makers will be encouraged to buy shares on dips and sell on rallies, fueling momentum if earnings or clinical data moves directionally.


Info Dump

Attribute Value
52 Week Change 0.55670106
Address1 2,265 Upper Middle Road East
Address2 Suite 602
All Time High 10.0
All Time Low 0.45
Ask 1.53
Ask Size 7
Audit Risk 9
Average Analyst Rating 1.4 - Strong Buy
Average Daily Volume10 Day 634,310
Average Daily Volume3 Month 596,993
Average Volume 596,993
Average Volume10Days 634,310
Beta 0.43
Bid 1.48
Bid Size 7
Board Risk 2
Book Value 0.12991153
City Oakville
Compensation As Of Epoch Date 1,735,603,200
Compensation Risk 10
Country Canada
Crypto Tradeable 0
Currency USD
Current Price 1.51
Current Ratio 4.156
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 1.5155
Day Low 1.39
Debt To Equity 0.702
Display Name Cardiol Therapeutics
Earnings Timestamp 1,775,046,600
Earnings Timestamp End 1,778,761,800
Earnings Timestamp Start 1,778,761,800
Ebitda -34,278,296
Ebitda Margins 0.0
Enterprise To Ebitda -4.307
Enterprise Value 147,635,680
Eps Current Year -0.37667
Eps Forward -0.17173651
Eps Trailing Twelve Months -0.28
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 905 481 2394
Fifty Day Average 1.12822
Fifty Day Average Change 0.38178003
Fifty Day Average Change Percent 0.33839148
Fifty Two Week Change Percent 55.670105
Fifty Two Week High 1.59
Fifty Two Week High Change -0.08000004
Fifty Two Week High Change Percent -0.05031449
Fifty Two Week Low 0.88
Fifty Two Week Low Change 0.63
Fifty Two Week Low Change Percent 0.71590906
Fifty Two Week Range 0.88 - 1.59
Financial Currency CAD
First Trade Date Milliseconds 1,547,562,600,000
Float Shares 96,488,554
Forward Eps -0.17173651
Forward P E -8.79254
Free Cashflow -13,026,343
Full Exchange Name NasdaqCM
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,775,001,600
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.02431
Held Percent Institutions 0.23216999
Implied Shares Outstanding 111,680,087
Industry Drug Manufacturers - Specialty & Generic
Industry Disp Drug Manufacturers - Specialty & Generic
Industry Key drug-manufacturers-specialty-generic
Ipo Expected Date 2,021-08-10
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.
Long Name Cardiol Therapeutics Inc.
Market us_market
Market Cap 168,636,928
Market State PREPRE
Max Age 86,400
Message Board Id finmb_424954803
Most Recent Quarter 1,767,139,200
Net Income To Common -33,818,872
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 167,907,744
Number Of Analyst Opinions 4
Open 1.43
Operating Cashflow -23,854,650
Operating Margins 0.0
Overall Risk 9
Payout Ratio 0.0
Phone 289 910 0850
Post Market Change -0.019299984
Post Market Change Percent -1.2781446
Post Market Price 1.4907
Post Market Time 1,776,469,406
Previous Close 1.41
Price Eps Current Year -4.008814
Price Hint 4
Price To Book 11.623295
Profit Margins 0.0
Quick Ratio 3.827
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.4
Region US
Regular Market Change 0.1
Regular Market Change Percent 7.0922
Regular Market Day High 1.5155
Regular Market Day Low 1.39
Regular Market Day Range 1.39 - 1.5155
Regular Market Open 1.43
Regular Market Previous Close 1.41
Regular Market Price 1.51
Regular Market Time 1,776,456,001
Regular Market Volume 1,341,450
Return On Assets -0.77312
Return On Equity -1.5875101
Sand P52 Week Change 0.38150132
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 3
Shares Outstanding 111,680,087
Shares Percent Shares Out 0.0177
Shares Short 1,981,485
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 2,245,658
Short Name Cardiol Therapeutics Inc.
Short Percent Of Float 0.0182
Short Ratio 2.29
Source Interval 15
State ON
Symbol CRDL
Target High Price 9.143476
Target Low Price 4.9718194
Target Mean Price 7.4376516
Target Median Price 7.8176565
Total Cash 21,416,684
Total Cash Per Share 0.191
Total Debt 125,523
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.28
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 1.113555
Two Hundred Day Average Change 0.39644504
Two Hundred Day Average Change Percent 0.3560175
Type Disp Equity
Volume 1,341,450
Website https://www.cardiolrx.com
Zip L6H 0G5